EANM procedure guidelines for therapy of benign thyroid disease

@article{Stokkel2010EANMPG,
  title={EANM procedure guidelines for therapy of benign thyroid disease},
  author={Marcel P. M. Stokkel and Daria Handkiewicz Junak and Michael Lassmann and Markus Dietlein and Markus Luster},
  journal={European Journal of Nuclear Medicine and Molecular Imaging},
  year={2010},
  volume={37},
  pages={2218-2228}
}
The purpose of the present guidelines on the 131I therapy of benign thyroid disorders formulated by the European Association of Nuclear Medicine (EANM) Therapy Committee is to provide advice to nuclear medicine clinicians on how to treat benign thyroid conditions employing optimal 131I activities. The recommendations were formulated based on recent literature and expert opinion regarding rationale, indications and contraindications for the use of 131I procedures, as well as the adequate 131I… Expand

Topics from this paper

Radioiodine Therapy of Hyperthyroidism (Toxic Goiter, Hyperfunctioning Nodule) and Non-Toxic Goiter: Procedures and Guidelines
TLDR
Recommendations have been formulated based on the EANM procedure guidelines, recent literature and expert opinion regarding indications for I-131 therapy and alternative treatment modalities, as well as the adequate radioiodine activities in different thyroid disorders and the administration and patient preparation techniques to be used. Expand
Radioiodine therapy in benign thyroid disorders. Evaluation of French nuclear medicine practices.
TLDR
The first nationwide French survey assessing the current practices in radioiodine treatment of hyperthyroidism shows that practices concerning the prescription of (131)I therapeutic doses are heterogeneous. Expand
Nuclear Medicine in Evaluation and Therapy of Nodular Thyroid
TLDR
The potential role of nuclear medicine imaging in the differentiation of benign from malignant follicular lesions is reviewed and how to approach incidental finding of increased uptake of 18F-FDG in a thyroid nodule is discussed. Expand
Challenges and current views on dosing of radioactive iodine in the treatment of benign thyroid disease
TLDR
Development of the new dosing protocols, as well as new insights into factors that affect therapeutic outcome, enable further improvement of both efficacy and safety of the radioactive iodine therapy for an individual patient. Expand
Radioiodine Therapy of Benign Thyroid Diseases
TLDR
This review aims to give information about the physical and biological characteristics of radioiodine-131, advantages and disadvantages, indications and contraindications for I-131 therapy, patient preperation and administiration, dose selection, precautions on possible side effects, evaluation of treatment response and make an overview on the clinical studies about I- 131 therapy. Expand
[Radioiodine therapy for benign thyroid diseases (version 5). German Guideline].
TLDR
The version 5 of the guideline for radioiodine therapy of benign thyroid disorders is an update of the version 4, which was published by the German Society of Nuclear Medicine in co-ordination with the German societies of Endocrinology and General- and Visceral-Surgery in 2007. Expand
Treatment of adult Graves' disease.
TLDR
Treatment strategy in Graves' disease firstly requires recovery of euthyroid status by antithyroid therapy, and in case of recurrence of hyperthyroidism, the various treatment options should be discussed with the patient. Expand
Radioiodine Treatment for Benign Thyroid Diseases
TLDR
This chapter summarizes all the points for a RAI treatment, an individualized therapy that can either be a first-line therapy, or an alternative therapy to neck surgery or to use of antithyroidal drugs after 1 year. Expand
Dosimetric methodology for 131I therapy for benign thyroid diseases
TLDR
This document lists the procedure to be followed in thyroid dosimetry and defines the sensitivity, calculating the S factors, estimating the cumulative activity and residence times and then calculating the dose. Expand
Management of adenomas and toxic multinodular goiters with Iodine 131
TLDR
It would be more effective to harmonise and work up on dosimetric personalized models allowing the calculation of the effective dose to be delivered to the autonomous nodule to be treated while preserving the normal thyroid parenchyma to optimise the patient's outcome and to favor extensive euthyroidism. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 95 REFERENCES
[Guideline for radioiodine therapy for benign thyroid diseases (version 3)].
TLDR
The version 3 of the guideline for radioiodine therapy for benign thyroid diseases presents first of all a revision of the version 2 and the pragmatic recommendations for the combined use ofRadioiodine and glucocorticoids remained unchanged in the 3rd version. Expand
[Guideline for radioiodine therapy for benign thyroid diseases (version 4)].
Version 4 of the guideline for radioiodine therapy for benign thyroid diseases includes an interdisciplinary consensus on decision making for antithyroid drugs, surgical treatment and radioiodineExpand
Radioiodine therapy of thyroid autonomy
TLDR
An overview of the pathogenesis of functional autonomy and its clinical relevance is provided and some differences in the preparation procedures in the guidelines of the American and the German Society of Nuclear Medicine are discussed with respect to therapy results and the subtypes of thyroid autonomy. Expand
An optimal treatment for pediatric Graves' disease is radioiodine.
TLDR
Properly administered, radioactive iodine remains an ideal form of treatment for Graves' disease in the pediatric population, and larger, rather than smaller, doses of (131)I should be given. Expand
[Procedure guideline for radioiodine therapy and 131iodine whole-body scintigraphy in paediatric patients with differentiated thyroid cancer].
The procedure guideline for radioiodine ((131)I) therapy and (131)I whole-body scintigraphy of differentiated thyroid cancer in paediatric patients is the counterpart to the procedure guidelinesExpand
Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?
TLDR
The effective thyroidal half-life and thyroidal uptake of 131I needs to be estimated individually to achieve optimal dosimetric results and might be used for a semi-individual calculation of therapeutic activity when an individual approach is not possible. Expand
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
TLDR
Evidence-based recommendations in response to the appointment as an independent task force by the American Thyroid Association to assist in the clinical management of patients with thyroid nodules and differentiated thyroid cancer represent, in the authors' opinion, contemporary optimal care for patients with these disorders. Expand
Long-term risks in hyperthyroid patients treated with radioiodine: is there anything new?
  • G. Lucignani
  • Medicine
  • European Journal of Nuclear Medicine and Molecular Imaging
  • 2007
TLDR
During the last two decades there has been wider acceptance of RAI as a safe and effective therapy for benign, non-toxic goitre, coupled with waning enthusiasm for the use of levothyroxine as the risks of this option have become more apparent. Expand
The management of subclinical hyperthyroidism by thyroid specialists.
TLDR
A case-based mail survey to solicit opinions from members of the American Thyroid Association about various issues that arise in the management of patients with subclinical hyperthyroidism found that the large majority of respondents recommended observation rather than active treatment for a young patient with a low but detectable serum TSH level. Expand
Radioiodine treatment for pediatric Graves' disease.
TLDR
It is suggested that a gland specific lower dosage of radioiodine treatment is potentially effective for pediatric GD, but a significant higher incidence of hypothyroidism compared with ATD was observed and high-quality randomised controlled clinical trials are needed to guide treatment choice. Expand
...
1
2
3
4
5
...